Mid-trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol.

Hinshaw, K; el-Refaey, H; Rispin, R; Templeton, A

Hinshaw, K; el-Refaey, H; Rispin, R; Templeton, A.

Affiliation

Hinshaw K; University Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, UK.

Br J Obstet Gynaecol ; 102(7): 559-60, 1995 Jul.

Article in En | MEDLINE | ID: mdl-7647059

Subject(s)

Abortion, Induced/methods; Fetus/abnormalities; Mifepristone; Misoprostol; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Female; Humans; Pregnancy; Pregnancy Trimester, Second

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Mifepristone / Misoprostol / Abortion, Induced / Fetus Limits: Adolescent / Adult / Female / Humans / Pregnancy Language: En Journal: Br J Obstet Gynaecol Year: 1995 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links